ArticleReviews in cardiovascular medicine2025
Impact of Intrinsic Capacity on 5-year Mortality of Older Patients With Cardiovascular Disease.
Article in Reviews in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between social support and life space mobility in older patients after percutaneous coronary intervention: mediating roles of health literacy and intrinsic capacity.Frontiers in public health · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Intrinsic capacity (IC) is defined as the combination of all physical and mental (including psychosocial) capacities that an individual can rely on at any given time. Previous studies have shown that a decline in IC is linked to an increased mortality rate. Thus, this study aimed to evaluate the impact of IC on the 5-year mortality of older people with cardiovascular disease. Methods: This was a prospective cohort study conducted at a tertiary-level A hospital in China between September 2018 and April 2019, with a follow-up period of 5 years. We applied a proposed IC score to assess the baseline IC of each participant. The primary clinical outcome was 5-year all-cause mortality. Results: A total of 524 older patients (mean age, 75.2 ± 6.5 years; 51.7% men) were enrolled from the cardiology ward. A total of 86 patients (16.5%) experienced all-cause mortality over the 5-year follow-up period. Compared with the survival group, patients in the mortality group were older (81.1 ± 5.7 vs. 74.0 ± 6.0; Conclusions: Among these older aged patients with cardiovascular disease, the IC score is independently associated with 5-year all-cause mortality, with a lower IC score indicating a poorer prognosis. Clinical Trial Registration: ChiCTR1800017204; date of registration: 07/18/2018. URL: https://www.chictr.org.cn/showproj.html?proj=28931.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.